JD vs OGEN · P/E 7.6, rev $187.20B vs rev $37.7K
JD.com Inc Adr (JD) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
JD currently screens at market cap $45.56B and trailing P/E 7.6. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the JD and OGEN stock pages for the full models.
Not investment advice.